实用医学杂志
實用醫學雜誌
실용의학잡지
THE JOURNAL OF PRACTICAL MEDICINE
2014年
7期
1084-1087
,共4页
张飞飞%彭新辉%杨浩%黄福美%何利伟%赖雯苑%彭健
張飛飛%彭新輝%楊浩%黃福美%何利偉%賴雯苑%彭健
장비비%팽신휘%양호%황복미%하리위%뢰문원%팽건
心肌疾病%导管射频消融术%左心室收缩功能%超声心动图
心肌疾病%導管射頻消融術%左心室收縮功能%超聲心動圖
심기질병%도관사빈소융술%좌심실수축공능%초성심동도
Cardiomyopathies%Cather ablation%Left ventricular systolic function%Echocardiography
目的:探讨射频消融术(RFCA)治疗心动过速型心肌病(TCM)后左室收缩功能的恢复情况。方法:收集2010年7月至2013年7月在我院因心律失常行消融治疗患者共715例,其中33例左室射血分数(LVEF)<50%,且术后升高≥15%的心动过速型心肌病患者纳入研究。经消融治疗1周后,早期LVEF改善明显的(与基线相比,术后第1周LVEF升高幅度≥25%)设为改善组,无明显变化的则为未改善组。所有患者术后1周、3个月、6个月、12个月均行超声心动图检查。结果:患者基线左室舒张末期内径及LVEF分别为(55±10.7)mm,(38±4.6)%。早期LVEF明显改善者16例,经过12个月的随访,改善组与未改善组相比,保持较高的LVEF[(69.2±4.2)%vs (58.1±6.9)%, P<0.001]。结论:RFCA被证明是一种较为安全而有效的治疗方法;房颤相关的TCM节律控制优于室率控制;术后早期 LVEF的改变对患者左室功能的恢复具有预测作用。
目的:探討射頻消融術(RFCA)治療心動過速型心肌病(TCM)後左室收縮功能的恢複情況。方法:收集2010年7月至2013年7月在我院因心律失常行消融治療患者共715例,其中33例左室射血分數(LVEF)<50%,且術後升高≥15%的心動過速型心肌病患者納入研究。經消融治療1週後,早期LVEF改善明顯的(與基線相比,術後第1週LVEF升高幅度≥25%)設為改善組,無明顯變化的則為未改善組。所有患者術後1週、3箇月、6箇月、12箇月均行超聲心動圖檢查。結果:患者基線左室舒張末期內徑及LVEF分彆為(55±10.7)mm,(38±4.6)%。早期LVEF明顯改善者16例,經過12箇月的隨訪,改善組與未改善組相比,保持較高的LVEF[(69.2±4.2)%vs (58.1±6.9)%, P<0.001]。結論:RFCA被證明是一種較為安全而有效的治療方法;房顫相關的TCM節律控製優于室率控製;術後早期 LVEF的改變對患者左室功能的恢複具有預測作用。
목적:탐토사빈소융술(RFCA)치료심동과속형심기병(TCM)후좌실수축공능적회복정황。방법:수집2010년7월지2013년7월재아원인심률실상행소융치료환자공715례,기중33례좌실사혈분수(LVEF)<50%,차술후승고≥15%적심동과속형심기병환자납입연구。경소융치료1주후,조기LVEF개선명현적(여기선상비,술후제1주LVEF승고폭도≥25%)설위개선조,무명현변화적칙위미개선조。소유환자술후1주、3개월、6개월、12개월균행초성심동도검사。결과:환자기선좌실서장말기내경급LVEF분별위(55±10.7)mm,(38±4.6)%。조기LVEF명현개선자16례,경과12개월적수방,개선조여미개선조상비,보지교고적LVEF[(69.2±4.2)%vs (58.1±6.9)%, P<0.001]。결론:RFCA피증명시일충교위안전이유효적치료방법;방전상관적TCM절률공제우우실솔공제;술후조기 LVEF적개변대환자좌실공능적회복구유예측작용。
Objective To determine the baseline echocardiographic characteristics and the time course and degree of recovery of left ventricular (LV) systolic dysfunction in patients with tachycardia-induced cardiomyopathy ( TCM ) . Methods Seven hundred and fifteen patients received radiofrequency cather ablation ( RFCA ) for tachycardiarrhymias from July 2010 to July 2013 were screened in this study. Only 33 patients with reduced left ventricular ejection fraction (LVEF) (LVEF<50% and improved≥15%) were diagnosed with tachycardia-induced cardiomyopathy and were included in the study. Patients with early improvement (over 25%increase in LVEF at 1-week follow-up compared to the baseline ) were enrolled in the improved group , and the rest patients were enrolled in the improved group. All Patients received transthoracic echocardiography for LV size and function detection at 1 week and at 3,6,12 months follow-up. Results The average baseline of the LV end-diastolic diameter, and the LVEF were (55 ± 10.7)mm and (38 ± 4.6)%, repectively. Early improvement ( over 25%increase in LVEF at 1-week follow-up compared to the baseline ) in the improved group was observed in 16 patients. Patients with early improvement had higher LVEF at 12-month follow-up compared to the patients without early improvement [(69.2± 4.2)% vs (58.1 ± 6.9)%, P < 0.001]. Conclusions RFCA is proved to be a relatively safe and effecient treatment method. Atrial fibrillation related to TCM , rhythm control is superior to the rate control. The early improvement in LVEF may potentially predict the complete reversibility of LV systolic dysfunction.